Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
20091.0k citationsS. Wijnhoven, Willie J.G.M. Peijnenburg et al.Nanotoxicologyprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
This map shows the geographic impact of B Roszek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Roszek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Roszek more than expected).
This network shows the impact of papers produced by B Roszek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Roszek. The network helps show where B Roszek may publish in the future.
Co-authorship network of co-authors of B Roszek
This figure shows the co-authorship network connecting the top 25 collaborators of B Roszek.
A scholar is included among the top collaborators of B Roszek based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with B Roszek. B Roszek is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
15 of 15 papers shown
1.
Sands, Andrew J, et al.. (2020). Guidance for post-market surveillance and market surveillance of medical devices, including in vitro diagnostics. Rivm (National Institute for Public Health and the Environment).8 indexed citations
Keizers, Peter H. J., et al.. (2016). Silicone breast implants in the Netherlands : A market surveillance study. Rivm (National Institute for Public Health and the Environment).3 indexed citations
5.
Roszek, B, et al.. (2015). Nanotechnologies in medical devices. Rivm (National Institute for Public Health and the Environment).3 indexed citations
6.
Wijnhoven, S., Willie J.G.M. Peijnenburg, Carla Herberts, et al.. (2009). Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology. 3(2). 109–138.1022 indexed citations breakdown →
7.
Roszek, B, et al.. (2008). Artificial organs - State-of-the-art technology for device-based and cell/tissue-based approaches. Rivm Repository (Netherlands National Institute for Public Health and the Environment).2 indexed citations
8.
Roszek, B, et al.. (2007). Assessment of technical documentation of medical devices for clinical investigation. Rivm Repository (Netherlands National Institute for Public Health and the Environment).2 indexed citations
9.
Roszek, B, et al.. (2005). Nanotechnology in medical applications:state-of-the-art in materials and devices. Rivm Repository (Netherlands National Institute for Public Health and the Environment).42 indexed citations
10.
Roszek, B, et al.. (2005). Nanotechnology in medical applications: possible risks for human health. Rivm Repository (Netherlands National Institute for Public Health and the Environment).15 indexed citations
11.
Roszek, B, et al.. (2005). Assessment of technical documentation of Class III medical devices. Rivm Repository (Netherlands National Institute for Public Health and the Environment).4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.